Elutia【ELUT】株式ニュース

名称	銘柄コード	市場	種別
Elutia Inc	ELUT	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	-0.11	-2.81%	3.80	06:24:43

始値	安値	高値	終値	前日終値
3.92	3.71	4.3199	3.80	3.91

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/6/19	05:15	EDGAR2	Form 8-K - Current report
2024/6/17	21:30	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/6/17	21:15	EDGAR2	Form 8-K - Current report
2024/6/17	21:01	GLOBE	Elutia Announces $13.26 Million Registered Direct Offering
2024/6/17	21:00	GLOBE	Elutia Announces FDA Clearance of EluPro®: The First..
2024/6/11	06:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/11	06:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/11	06:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/08	06:00	EDGAR2	Form 8-K - Current report
2024/5/14	06:01	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/13	21:00	GLOBE	Elutia to Showcase BioEnvelope Product Line at Heart Rhythm..
2024/5/10	06:26	EDGAR2	Form 8-K - Current report
2024/5/10	05:05	GLOBE	Elutia Announces First Quarter 2024 Results: SimpliDerm®..
2024/5/03	05:05	GLOBE	Elutia to Report First Quarter 2024 Financial Results on..
2024/4/25	05:05	GLOBE	Elutia to Present at the Planet MicroCap Showcase: VEGAS..
2024/3/11	22:15	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/3/08	06:24	EDGAR2	Form 8-K - Current report
2024/3/08	06:05	GLOBE	Elutia Reports Fourth Quarter and Full Year 2023 Financial..
2024/2/23	06:05	GLOBE	Elutia to Report Fourth Quarter and Full Year 2023 Financial..
2024/2/15	06:40	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
2024/2/03	06:30	EDGAR2	Form 8-K - Current report
2024/1/26	06:56	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
2024/1/13	07:00	EDGAR2	Form 8-K - Current report
2024/1/11	07:00	EDGAR2	Form 8-K - Current report
2024/1/11	06:05	GLOBE	Elutia Regains Compliance with Nasdaq Listing Requirements
2024/1/10	06:17	EDGAR2	Form SC 13D/A - General statement of acquisition of..
2024/1/09	06:12	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/28	06:30	EDGAR2	Form 8-K - Current report
2023/12/18	22:00	GLOBE	Elutia Submits CanGarooRM® Antibiotic-Eluting Biomatrix for..
2023/12/09	06:04	EDGAR2	Form 8-K - Current report
2023/12/06	06:54	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/12/05	14:15	EDGAR2	Form EFFECT - Notice of Effectiveness
2023/11/21	06:53	EDGAR2	Form S-3 - Registration statement under Securities Act of..
2023/11/21	06:02	EDGAR2	Form 8-K - Current report
2023/11/16	07:26	EDGAR2	Form 8-K - Current report
2023/11/14	06:05	GLOBE	Elutia Reports 26% Year-Over-Year Sales Growth of..
2023/11/09	23:19	EDGAR2	Form 8-K - Current report
2023/11/09	22:30	GLOBE	Elutia Completes Divestiture of Orthobiologics Business Unit..
2023/11/08	06:04	EDGAR2	Form 8-K - Current report
2023/11/07	06:05	GLOBE	Elutia to Report Third Quarter 2023 Financial Results on..
2023/10/18	21:00	PRNUS	SWK Holdings Highlights Recent Achievements and Provides..
2023/10/07	04:28	EDGAR2	Form SC 13D/A - General statement of acquisition of..
2023/10/06	05:50	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/9/22	05:05	EDGAR2	Form 8-K - Current report
2023/9/20	21:30	GLOBE	Elutia to Participate in a Panel Discussion at the Cantor..
2023/9/19	21:36	GLOBE	Elutia Announces Private Placement for Proceeds Up to $26..
2023/9/19	21:30	EDGAR2	Form 8-K - Current report
2023/9/19	05:08	GLOBE	Elutia Announces Sale of Orthobiologics Business Unit for..
2023/9/08	21:30	GLOBE	Elutia to Present at the H.C. Wainwright 25th Annual Global..
2023/9/07	05:05	GLOBE	Aziyo Biologics Rebrands as Elutia to Reflect Strategic..